TAMBRIZA
Dead / Abandoned — Abandoned — no statement of use filed (as of 20 Jun 2011)
What this means for you
This application is over — abandoned 20 Jun 2011. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 77266860
- Mark type
- Stylized text
- Filed
- 29 Aug 2007
- Published for opposition
- 26 Feb 2008
- Abandoned
- 20 Jun 2011
- Attorney of record
- James M. McCarthy
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cardiovascular, cardiopulmonary, genitourinary, central nervous system, endocrine, gastrointestinal, gynecological, hematological, immunological, hormonal, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological, neurodegenerative and viral related diseases and disorders; pharmaceutical preparations for the treatment of pain, sepsis, diabetes, apopecia, allergies, erectile dysfunction, sexual dysfunction, obesity, and HIV/AIDS
Owner
- METHYLGENE INC., MONTREAL, CA
- CELGENE CORPORATION, SUMMIT, NJ, US
- Pharmion Corporation, Boulder, CO, US
- Pharmion Corporation, Boulder, CO, US
Prosecution history
- 27 Jun 2012 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 20 Jun 2011 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 20 Jun 2011 — ABANDONMENT - NO USE STATEMENT FILED
- 23 Nov 2010 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Nov 2010 — SOU EXTENSION 5 GRANTED
- 18 Nov 2010 — SOU EXTENSION 5 FILED
- 18 Nov 2010 — SOU TEAS EXTENSION RECEIVED
- 04 Aug 2010 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 22 May 2010 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 May 2010 — SOU EXTENSION 4 GRANTED
- 20 May 2010 — SOU EXTENSION 4 FILED
- 20 May 2010 — SOU TEAS EXTENSION RECEIVED
- 24 Nov 2009 — SOU EXTENSION 3 GRANTED
- 09 Nov 2009 — SOU EXTENSION 3 FILED
- 09 Nov 2009 — SOU TEAS EXTENSION RECEIVED